EcoDrugPlus

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSPFOG00000013318
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor (A Type Iii Receptor Tyrosine Kinase)

Ensembl ID : ENSPFOG00000017312
Gene Symbol: KDR
1 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSPFOG00000017670
Gene Symbol: KIF11
1 Cross references
201 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPFOG00000014848
Gene Symbol: KIF5B
4 Cross references
236 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPFOG00000013346
Gene Symbol: KIF5B
2 Cross references
234 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSPFOG00000003453
Gene Symbol: LTA4H
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPFOG00000001010
Gene Symbol: LOC103144591
3 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPFOG00000004026
Gene Symbol: LOC103148609
3 Cross references
167 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPFOG00000000975
Gene Symbol: LOC103144590
3 Cross references
142 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSPFOG00000009187
Gene Symbol: LOC103145124
4 Cross references
200 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSPFOG00000010119
Gene Symbol: KDM1A
3 Cross references
212 Possible Orthologues:

Lysyl Oxidase Homolog 2b-Like

Ensembl ID : ENSPFOG00000006854
Gene Symbol: LOC103152815
3 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).